Review on Antimicrobial Resistance publishes new paper: Tackling a global health crisis: initial steps
Independent review recommends first steps to tackle drug-resistant superbugs.
In December, the Review on Antimicrobial Resistance (AMR) reported that unless action is taken to address this huge global problem, it could cost the world at least an additional 10 million lives a year by 2050, more than the number of people who currently die from cancer. It would also have a cumulative cost of at least 100 trillion USD, more than one and a half times annual world GDP
today. With so much at stake, and resistant infections already claiming more than 700,000 lives a year, time is critical.
The Review is now publishing its second paper, outlining specific steps for action to tackle the rise of drug-resistant infections worldwide. This includes the establishment of a global AMR Innovation Fund; steps to help maintain the effectiveness of existing antibiotics; and action to address an emerging skills shortage in this crucial field of research.
Read the press release here.
Download the report from here.
